Dual-ligand functionalized liposomes with iRGD/trastuzumab co-loaded with gefitinib and lycorine for enhanced metastatic breast cancer therapy
Journal of Liposome Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 15
Published: Feb. 2, 2025
Personalized
treatment
strategies
have
greatly
improved
the
efficacy
of
anticancer
drugs.
Nanocarriers,
especially
liposomes,
function
as
excellent
platform
for
delivery
both
hydrophilic
and
hydrophobic
agents.
iRGD
is
a
peptide
composed
9-amino
acid
denoted
(iRGDP),
enhances
selective
intratumoral
Trastuzumab
(TMAB),
mainly
targets
HER2-positive
advanced
stage
breast
cancer
an
FDA-approved
monoclonal
antibody.
Gefitinib
(GEB)
drug,
effective
against
metastatic
(MBC),
while
Lycorine
hydrochloride
(LCOH),
naturally
derived
compound,
possess
anti-inflammatory
properties.
This
research
emphasizing
on
preparation
GEB
LCOH-entrapped
TPGS-COOH
coated-liposomes,
camouflaged
with
antibody
(TMAB)
cyclic
(iRGDP)
targeted
in
MBC
therapy.
The
developed
multifunctional
liposomes
were
studied
extensive
vitro
cell
line
studies
MCF-7
cells.
half-maximum
inhibitory
concentration
(IC-50)
values
LCOH
co-loaded
single
functionalized
liposome
(SFL)
(iRGDP-LiP,
TMAB-LiP)
dual-functionalized
(DFL)
(iRGDP-TMAB-LiP)
cells
1.04
±
0.023
μg/mL,
0.71
0.018
0.56
0.028
respectively.
Inverted
confocal
laser
scanning
microscopy
(ICLSM)
revealed
enhanced
cellular
internalization
SFL
DFL-treated
groups
tagged
coumarin-6
rhodamine-B
dye
compared
to
conventional
liposome.
scratch
assay
marked
reduction
migration,
DAPI
staining
confirmed
nuclear
condensation
(NC)
fragmentation
(NF)
groups.
Moreover,
flow
cytometry
demonstrated
early
late
apoptosis
DFL
These
findings
indicate
that
holds
promise
multifaceted
therapeutic
approach
Language: Английский
Lycorine hydrochloride Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting TRIM22 and Inhibiting the JAK2/STAT3 and Erk Pathways
Jingyan Liu,
No information about this author
Liangxian Qiu,
No information about this author
Jialing Chen
No information about this author
et al.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(5), P. 718 - 718
Published: Feb. 20, 2025
Tumor
metastasis
and
poor
drug
efficacy
are
two
of
the
most
common
causes
therapeutic
failure
in
cancer
patients.
The
underlying
molecular
mechanism
requires
further
exploration,
novel
effective
curative
strategies
urgently
needed.
Nature
is
a
rich
source
drugs,
Lycorine
hydrochloride
(Lyc.HCL)
natural
alkaloid
with
tremendous
potential.
However,
mechanisms
its
antitumor
activity
still
unknown.
In
current
study,
we
investigated
effects
Lyc.HCL
against
esophageal
squamous
cell
carcinomas
(ESCCs),
which
pose
serious
threats
to
human
life.
An
MTS
assay
clone
formation
were
used
assess
viability
ESCC
lines
after
treatment
vitro.
Apoptosis
cycle
regulation
analyzed
using
flow
cytometry.
Wound
healing
Transwell
assays
analyze
migration,
while
invasion
was
Matrigel
assay.
We
detected
expression
tripartite
motif-containing
22
(TRIM22)
through
immunohistochemistry
Western
blotting.
A
docking
experiment
performed
explore
targets
Lyc.HCL.
levels
Janus
kinase
2
(JAK2)/signal
transducer
activator
transcription
3
(STAT3)
phosphoinositide
3-kinase
(PI3K)/protein
B
(AKT)/extracellular
signal-regulated
(Erk)
pathway
components
rescue
determine
potential
role
TRIM22.
addition,
explored
vivo
anti-ESCC
by
it
treat
tumor-bearing
mice.
found
inhibit
carcinoma
proliferation
both
vitro
blocking
at
G2
phase,
inhibiting
migration
invasion.
that
TRIM22
protein
highly
expressed
ESCCs
but
not
normal
tissue.
directly
targeted
TRIM22,
decreasing
JAK2/STAT3
Erk
signaling
pathways,
vivo.
Using
animal
experiments,
observed
depletion
delayed
tumor
growth,
this
effect
significantly
reversed
upon
overexpression.
Taken
together,
these
findings
demonstrate
can
effectively
suppress
targeting
regulating
pathways.
These
results
suggest
may
serve
as
for
ESCC,
emerging
promising
target
treatment.
Language: Английский
NMR Metabolomic Profiling of Differentiated SH-SY5Y Neuronal Cells: Amyloid-β Toxicity and Protective Effects of Galantamine and Lycorine
Cells,
Journal Year:
2025,
Volume and Issue:
14(7), P. 525 - 525
Published: April 1, 2025
Alzheimer’s
disease
(AD)
is
a
multifactorial
neurodegenerative
disorder
characterized
by
metabolic
dysregulation,
oxidative
stress,
amyloid-β
(Aβ)
aggregation,
metal
dyshomeostasis,
and
mitochondrial
dysfunction.
Current
treatments
provide
only
symptomatic
relief,
highlighting
the
need
for
novel
therapeutic
strategies.
This
study
investigates
effects
of
alkaloids
galantamine
(GAL)
lycorine
(LYC)
in
differentiated
SH-SY5Y
neuroblastoma
cells,
an
established
vitro
model
AD,
which
acquire
neuronal
phenotype
upon
differentiation.
Using
untargeted
targeted
NMR-based
metabolomics
combined
with
multivariate
statistical
analysis,
we
analyzed
extracellular
profiles
under
basal
conditions
following
Aβ42
exposure,
both
presence
absence
GAL
LYC.
Our
findings
reveal
distinct
responses
to
Aβ
toxicity,
significant
alterations
pyruvate
glutamine
metabolism.
Both
LYC
contributed
restoration
lysine
homeostasis,
but
had
more
pronounced
effect,
better
sustaining
cellular
energy
balance
function.
Unlike
LYC,
treatment
was
associated
accumulation,
response
between
two
compounds.
These
variations
may
reflect
mechanisms
action,
potentially
influencing
their
roles
counteracting
Aβ-induced
toxicity.
highlights
value
profiling
assessing
neuroprotective
agents
reinforces
potential
natural
this
context.
Language: Английский
Role of macrophage ATP metabolism disorder in SiO2‑induced pulmonary fibrosis: a review
Huijie Hu,
No information about this author
Yuanyuan Fu,
No information about this author
Shu‐ling Du
No information about this author
et al.
Purinergic Signalling,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 13, 2025
Language: Английский
Advances in Fluorescent Natural Products for Imaging Localization and Biological Applications
Guiqian Fang,
No information about this author
Daili Liu,
No information about this author
Yuanzhuo Wang
No information about this author
et al.
European Journal of Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 117759 - 117759
Published: May 1, 2025
Language: Английский
Histochemical Localization and Cytotoxic Potential of Alkaloids in Phaedranassa lehmannii
Plants,
Journal Year:
2024,
Volume and Issue:
13(22), P. 3251 - 3251
Published: Nov. 20, 2024
Plants
of
the
subfamily
Amaryllidoideae
are
a
source
unique
and
bioactive
alkaloids
called
Amaryllidaceae
alkaloids.
The
study
their
anticancer
potential
has
intensified
in
recent
years.
This
work
aims
to
locate
characterize
profile
cytotoxic
biosynthesized
stored
different
tissues
Language: Английский